 | | PRD_001256 | | Name: | bifunctional peptide | | Formula: | C39 H43 N5 O5 | | Definition date: | 2015-01-14 | | Last modified: | 2015-01-14 |
|
 | | PRD_001172 | | Name: | nosiheptide bound form | | Formula: | C51 H53 N13 O12 S6 | | Definition date: | 2014-12-10 | | Last modified: | 2014-12-10 |
|
 | | PRD_001208 | | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)I(LYV)KKK | | Formula: | C106 H165 N27 O28 P | | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | | Definition date: | 2014-12-03 | | Last modified: | 2014-12-03 |
|
 | | PRD_001209 | | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)IKKKK | | Formula: | C103 H161 N25 O22 | | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | | Definition date: | 2014-12-03 | | Last modified: | 2014-12-03 |
|
 | | PRD_002118 | | Name: | N-[(4Z)-6-oxo-6-phenylhex-4-enoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C39 H53 N6 O10 P | | Definition date: | 2014-12-03 | | Last modified: | 2014-12-03 |
|
 | | PRD_001254 | | Name: | PL-2 | | Formula: | C29 H45 N6 O9 P | | Definition date: | 2014-11-19 | | Last modified: | 2014-11-19 |
|
 | | PRD_002115 | | Name: | (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-24-{(2R)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl}-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | | Formula: | C69 H125 N13 O13 | | Definition date: | 2014-11-12 | | Last modified: | 2014-11-12 |
|
 | | PRD_001080 | | Name: | Peptide inhibitor MPT-DPP-ARG-G-LEU-NH2 | | Formula: | C20 H40 N9 O5 S | | Definition date: | 2014-10-15 | | Last modified: | 2014-10-15 |
|
 | | PRD_001191 | | Name: | iCAL36(BRB-K-1) peptide | | Formula: | C58 H86 Br N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001192 | | Name: | iCAL36(TFA-K-1) peptide | | Formula: | C53 H82 F3 N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001193 | | Name: | iCAL36(FLB-K-1) peptide | | Formula: | C58 H86 F N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001194 | | Name: | iCAL36(Ac-K-5) peptide | | Formula: | C48 H86 N15 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001195 | | Name: | iCAL36(Ac-K-4) peptide | | Formula: | C54 H89 N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001196 | | Name: | iCAL36(Ac-K-3) peptide | | Formula: | C55 H89 N16 O15 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001197 | | Name: | iCAL36(Ac-K-1) peptide | | Formula: | C53 H85 N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001053 | | Name: | N-[(benzyloxy)carbonyl]glycyl-N-[(2S,3R)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]glycinamide | | Formula: | C22 H26 Cl N3 O5 | | Description: | The chlorormethyl ketone inhibitor linked to the protein through two covalent bonds with the active site serine and histidine | | Definition date: | 2013-05-08 | | Last modified: | 2014-09-29 |
|
 | | PRD_001222 | | Name: | bicyclic peptide UK601 (bicyclic 1) | | Formula: | C59 H101 N24 O17 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001223 | | Name: | bicyclic peptide UK602 (bicyclic 1) | | Formula: | C56 H96 N23 O16 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001224 | | Name: | bicyclic peptide UK603 (bicyclic 1) | | Formula: | C59 H101 N24 O17 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001225 | | Name: | bicyclic peptide UK604 (bicyclic 2) | | Formula: | C56 H96 N23 O16 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001226 | | Name: | bicyclic peptide UK607 (bicyclic) | | Formula: | C64 H110 N25 O18 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001227 | | Name: | bicyclic peptide UK603 (bicyclic 2) | | Formula: | C59 H101 N24 O17 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001232 | | Name: | Alpha-conotoxin ImI mutant | | Formula: | C54 H84 N20 O15 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001251 | | Name: | ACE-PHE-ALA-THR-ALA-0QE | | Formula: | C22 H31 Cl N4 O6 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001252 | | Name: | ACE-ILE-ALA-THR-ALA-0QE | | Formula: | C19 H33 Cl N4 O6 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
